- Home
- VIVS vs IBO Comparison
VIVS vs IBO Comparison
Compare VIVS & IBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VIVS
- IBO
- Stock Information
- Founded
- VIVS 2007
- IBO 2018
- Country
- VIVS United States
- IBO United States
- Employees
- VIVS N/A
- IBO N/A
- Industry
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- IBO
- Sector
- VIVS Health Care
- IBO
- Exchange
- VIVS Nasdaq
- IBO NYSE
- Market Cap
- VIVS 5.0M
- IBO 5.8M
- IPO Year
- VIVS N/A
- IBO 2024
- Fundamental
- Price
- VIVS $2.21
- IBO $0.69
- Analyst Decision
- VIVS
- IBO
- Analyst Count
- VIVS 0
- IBO 0
- Target Price
- VIVS N/A
- IBO N/A
- AVG Volume (30 Days)
- VIVS 70.9K
- IBO 635.2K
- Earning Date
- VIVS 08-05-2025
- IBO 08-23-2025
- Dividend Yield
- VIVS N/A
- IBO N/A
- EPS Growth
- VIVS N/A
- IBO N/A
- EPS
- VIVS N/A
- IBO N/A
- Revenue
- VIVS $144,000.00
- IBO N/A
- Revenue This Year
- VIVS $42.38
- IBO N/A
- Revenue Next Year
- VIVS $15.42
- IBO N/A
- P/E Ratio
- VIVS N/A
- IBO N/A
- Revenue Growth
- VIVS 32.11
- IBO N/A
- 52 Week Low
- VIVS $1.41
- IBO $0.36
- 52 Week High
- VIVS $21.96
- IBO $6.17
- Technical
- Relative Strength Index (RSI)
- VIVS N/A
- IBO N/A
- Support Level
- VIVS N/A
- IBO N/A
- Resistance Level
- VIVS N/A
- IBO N/A
- Average True Range (ATR)
- VIVS 0.00
- IBO 0.00
- MACD
- VIVS 0.00
- IBO 0.00
- Stochastic Oscillator
- VIVS 0.00
- IBO 0.00
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases. It is now offering liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development.
About IBO IMPACT BIOMEDICAL INC
Impact BioMedical Inc focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune-related diseases. The company is also developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. Its technologies inlcude Linebacker, Laetose, 3F, and Equivir.